18F-fluorocholine PET/CT Imaging in Hyperparathyroidism

NCT03203668 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2017-07-02

No results posted yet for this study

Summary

To assess the efficiency of 18F-fluorocholine PET/CT in localization of hyperfunctioning parathyroid tissue in hyperparathyroidism, thereby enabling minimally invasive surgical approaches with fewer complications and comparable success rates

Conditions

  • Hyperparathyroidism

Interventions

RADIATION

18F-choline PET/CT

18F-choline PET/CT imaging (neck, mediastinum)

Sponsors & Collaborators

  • Institute of Oncology Ljubljana

    collaborator OTHER
  • University Medical Centre Ljubljana

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03203668 on ClinicalTrials.gov